Drug
18f Mfbg For Administration
18f Mfbg For Administration: highest development phase Phase 1/2, developed by Illumina. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Illumina
Trials
| Drug | Phase | Indication |
|---|---|---|
| 18F-mFBG for intravenous administration NCT04535193 | Phase 1/2 | Cardiovascular Diseases |
Latest
No recent events.
Follow 18f Mfbg For Administration on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.